For every drug that makes it to the finish line, another nine don’t succeed. This alarming failure rate can be traced to reliance on 2D cell cultures or animal models that don’t closely mimic complex human biology, often leading to inaccurate predictions of a drug’s potential and extended drug development timelines.
New, innovative, 3D models – such as organoids – enable more accurate predictions of patient responses to novel medicines early on, while streamlining drug development time and cost.
In this session, experts discuss the promise of 3D biology for advancing drug discovery.
Type: Online Event